Regeneron Pharmaceuticals' Interest & Investment Income fell 11492.17% to -$6.0 million in Q4 2017 from the same period last year, while for Dec 2017 it was -$25.1 million, marking a year-over-year decrease of 24911.74%. This contributed to the annual value of -$25.1 million for FY2017, which is 24911.74% down from last year.
According to the latest figures from Q4 2017, Regeneron Pharmaceuticals' Interest & Investment Income is -$6.0 million, which was down 11492.17% from -$6.2 million recorded in Q3 2017.
Over the past 5 years, Regeneron Pharmaceuticals' Interest & Investment Income peaked at $2.1 million during Q3 2015, and registered a low of -$18.2 million during Q4 2015.
Its 5-year average for Interest & Investment Income is -$2.5 million, with a median of -$873500.0 in 2016.
Its Interest & Investment Income has fluctuated over the past 5 years, first soared by 10548.25% in 2014, then tumbled by 156666.67% in 2016.
Regeneron Pharmaceuticals' Interest & Investment Income (Quarter) stood at -$2.3 million in 2013, then soared by 174.24% to $1.7 million in 2014, then crashed by 1186.11% to -$18.2 million in 2015, then skyrocketed by 84.58% to -$2.8 million in 2016, then crashed by 114.92% to -$6.0 million in 2017.
Its Interest & Investment Income stands at -$6.0 million for Q4 2017, versus -$6.2 million for Q3 2017 and -$5.4 million for Q2 2017.

Peer Comparison

Historic Data

Download Data 🔒

Date	Value